Literature DB >> 22863385

Thyroid microcarcinoma.

Furio Pacini1.   

Abstract

Nowadays the most commonly occurring differentiated thyroid cancer in many countries is a microcarcinoma in patients older than 45 years, incidentally found during neck ultrasound. In view of their low morbidity and mortality, the crucial point is how to manage such microcarcinomas. Recently published European and American guidelines aim to minimize the diagnostic and therapeutic procedures without affecting the diagnostic accuracy and the therapeutic effectiveness, keeping in mind that we are dealing with patients who have a normal life expectancy and to whom we have to guarantee an excellent quality of life. The present review will summarize the clinical and pathological features of thyroid microcarcinoma, including its definition, prevalence, presentation, pathology, genetic, clinical impact and will try to derive from them a rationale for therapeutic and diagnostic intervention.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22863385     DOI: 10.1016/j.beem.2012.07.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  10 in total

1.  Improvement of quality of life in patients with benign goiter after surgical treatment.

Authors:  Branka R Bukvic; Vladan R Zivaljevic; Sandra B Sipetic; Aleksandar D Diklic; Katarina M Tausanovic; Ivan R Paunovic
Journal:  Langenbecks Arch Surg       Date:  2014-07-08       Impact factor: 3.445

Review 2.  [Current treatment strategies for papillary thyroid microcarcinoma].

Authors:  J Plzák; J Astl; G Psychogios; J Zenk; P Laštůvka; J Betka
Journal:  HNO       Date:  2013-04       Impact factor: 1.284

3.  Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.

Authors:  Vivian Y Park; Eun-Kyung Kim; Hye Sun Lee; Hee Jung Moon; Jung Hyun Yoon; Jin Young Kwak
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Acoustic radiation force impulse imaging: a new tool for the diagnosis of papillary thyroid microcarcinoma.

Authors:  Yi-Feng Zhang; Chang Liu; Hui-Xiong Xu; Jun-Mei Xu; Jing Zhang; Le-Hang Guo; Shu-Guang Zheng; Lin-Na Liu; Xiao-Hong Xu
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

5.  Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.

Authors:  Marina Santos; Teresa Azevedo; Teresa Martins; Fernando J Rodrigues; Manuel C Lemos
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

6.  Diagnostic Value of Conventional Ultrasonography Combined with Contrast-Enhanced Ultrasonography in Thyroid Imaging Reporting and Data System (TI-RADS) 3 and 4 Thyroid Micronodules.

Authors:  Yingxian Liu; Hao Wu; Qing Zhou; Jiamei Gou; Jinmei Xu; Yan Liu; Qin Chen
Journal:  Med Sci Monit       Date:  2016-08-31

7.  Papillary thyroid microcarcinoma: the significance of high risk features.

Authors:  Nori L Bradley; Sam M Wiseman
Journal:  BMC Cancer       Date:  2017-02-16       Impact factor: 4.430

8.  A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature.

Authors:  Sasan Mirfakhraee; Dana Mathews; Lan Peng; Stacey Woodruff; Jeffrey M Zigman
Journal:  Thyroid Res       Date:  2013-05-04

9.  Interstitial fibrosis in papillary thyroid microcarcinoma and its association with biological behavior.

Authors:  Xun Liu; Shuai Zhang; Qinwei Gang; Shikai Shen; Jian Zhang; Yu Lun; Dongdong Xu; Zhiquan Duan; Shijie Xin
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

10.  Short-term Follow-up US Leads to Higher False-positive Results Without Detection of Structural Recurrences in PTMC.

Authors:  Jung Hyun Yoon; Hye Sun Lee; Eun-Kyung Kim; Ji Hyun Youk; Hyun Gi Kim; Hee Jung Moon; Jin Young Kwak
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.